A review: zinc oxide nanoparticles - friends or enemies?


Journal

International journal of environmental health research
ISSN: 1369-1619
Titre abrégé: Int J Environ Health Res
Pays: England
ID NLM: 9106628

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 11 8 2020
medline: 8 3 2022
entrez: 11 8 2020
Statut: ppublish

Résumé

Modern nanotechnology allows obtaining zinc oxide nanomaterials with unique properties that let its use in a wide range of commercial applications. Direct contact with these particles as well as their release into the environment is almost inevitable. This review aims to consider whether the toxicity of zinc oxide nanoparticles found in numerous test models is a real threat to humans and plants. Emerging reports indicated both the risks and benefits associated with the use of zinc oxide nanoparticles in a manner dependent on the concentration and a method of synthesis, as well as the tested object. The amounts needed to achieve the antibacterial activity of ZnO-NPs, and the reported amounts of these nanoparticles in consumer products are sufficient to have a negative impact on living organisms. The most sensitive to their action are human cells, and the mechanism of cytotoxicity is mainly associated with the formation of oxidative stress caused by the action of zinc ions. ZnO-NPs in small concentration can have positive affect to plants, but it poses a threat to more sensitive ones.

Identifiants

pubmed: 32772735
doi: 10.1080/09603123.2020.1805415
doi:

Substances chimiques

Zinc Oxide SOI2LOH54Z

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

885-901

Auteurs

Agnieszka Czyżowska (A)

Department of Biochemistry and Biophysics, Institute of Biology, Pedagogical University of Cracow, Kraków, Poland.

Anna Barbasz (A)

Department of Biochemistry and Biophysics, Institute of Biology, Pedagogical University of Cracow, Kraków, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH